Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
ID06785350

Minimum Effective Dose of Incisional Local Infiltration Betamethasone for the Prevention of Pain After Spinal Surgery: a Randomised Controlled Trial

Led by Beijing Tiantan Hospital · Updated on 2025-07-16

535

Participants Needed

1

Research Sites

13 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Postoperative pain at the site of a surgical incision is a common issue after spine surgery and can lead to slower recovery, longer hospital stays, and increased risk of complications. Researchers are studying the best concentration of anti-inflammatory drugs combined with pain relievers for local injection around spinal surgical incisions to reduce this pain. This randomized controlled trial aims to find the minimum effective dose of betamethasone, an anti-inflammatory steroid, combined with ropivacaine, a local anesthetic, to prevent pain after spinal surgery. Participants will receive one of five different local infiltration treatments before the incision: four groups will receive varying concentrations of betamethasone combined with 0.5% ropivacaine, while a control group receives only 0.5% ropivacaine. Standard general anesthesia with drugs like sufentanil and propofol will be given during surgery. After surgery, patients will use a patient-controlled analgesia (PCA) pump delivering sufentanil and ondansetron to manage pain and nausea. The study will track the use of this pump, additional pain medications, and other parameters for up to 3 months. During the study, participants will be assessed on their pain levels using visual scales at multiple times up to 3 months post-surgery. Researchers will also measure opioid consumption, sedation levels, nausea, satisfaction, quality of life, disability, scar appearance, and any side effects. The main outcome is the amount of sufentanil used via PCA within 48 hours after surgery. Close monitoring of medication use and intraoperative details will continue throughout the study to evaluate the pain prevention effect of the local infiltration solutions.

CONDITIONS

Brief Title

Minimum Effective Dose of Incisional Local Infiltration Betamethasone for the Prevention of Pain After Spinal Surgery

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients scheduled for spine surgery under general anesthesia involving cervical, thoracic, or lumbar spine within three levels
  • Age between 18 and 65 years
  • American Society of Anaesthesiologists Classification of I or II
Not Eligible

You will not qualify if you...

  • Patients who refuse to participate
  • Allergy to ropivacaine, betamethasone, or opioid medications
  • History of drug or alcohol abuse
  • Abnormal kidney or liver function tests
  • Body mass index less than 15 kg/m2 or greater than 35 kg/m2
  • History of spinal surgery
  • Presence of peri-incisional infection
  • History of stroke or serious neurological disease
  • History of diabetes or other metabolic disorders
  • History of psychological disorders
  • Current use of systemic steroids
  • Pregnancy or breastfeeding
  • Glasgow Coma Scale score less than 15 before surgery
  • Unable to provide written informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Surgery day and 48 hours postoperatively

Participants receive local infiltration of betamethasone and ropivacaine before spinal surgery and standard general anesthesia. Postoperative pain management includes use of a patient-controlled analgesia (PCA) pump and supplemental oral analgesics as needed.

1 preoperative visit, 1 surgery day visit, and multiple visits during 48-hour postoperative PCA monitoring

Follow-up

Duration - Up to 3 months postoperatively

Participants are monitored for pain, analgesic use, side effects, and recovery outcomes including quality of life and scar assessment up to 3 months after surgery.

Visits at 2 hours, 4 hours, 8 hours, 24 hours, 48 hours, 72 hours, 1 week, 2 weeks, 6 weeks, and 3 months postoperatively

Trial Site Locations

Total: 1 location

1

Beijing Tiantan Hospital

Beijing, Beijing Municipality, China, 100070

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

5

Similar Trials

Acute Effects of Transcutaneous Electrical Nerve Stimulation...

Pain Management

Actively Recruiting

1 location

An Open, Parallel-group, Randomized Medical Device Study to ...

Spine Surgery

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Minimum effective dose of betamethasone for incisional local infiltration for the prevention of postoperative pain after spine surgery: study protocol for a randomised controlled trial.

Yitong Wang, Bo Han, Chunmei Zhao...

https://pubmed.ncbi.nlm.nih.gov/41022457